Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.

× No keyword cloud information.

16 in total

1. Oligohydramnios associated with administration of weekly paclitaxel for triple-negative breast cancer during pregnancy.

Authors: M P Shieh; R S Mehta
Journal: Ann Oncol Date: 2011-07-28 Impact factor: 32.976

2. Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.

Authors: Aida Kuzucan; Jeon-Hor Chen; Shadfar Bahri; Rita S Mehta; Philip M Carpenter; Peter T Fwu; Hon J Yu; David J B Hsiang; Karen T Lane; John A Butler; Stephen A Feig; Min-Ying Su
Journal: Clin Breast Cancer Date: 2012-04 Impact factor: 3.225

3. Dramatic Response to Carboplatin, Paclitaxel, and Radiation in a Patient With Malignant Myoepithelioma of the Breast.

Authors: Phu N Tran; Lefan Zhuang; Chaital I Nangia; Rita S Mehta
Journal: Oncologist Date: 2016-07-29

4. Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer.

Authors: Leona Bessonova; Thomas H Taylor; Rita S Mehta; Jason A Zell; Hoda Anton-Culver
Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-01-07 Impact factor: 4.254

5. Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab.

Authors: Shadfar Bahri; Jeon-Hor Chen; Rita S Mehta; Philip M Carpenter; Ke Nie; Soon-Young Kwon; Hon J Yu; Orhan Nalcioglu; Min-Ying Su
Journal: Ann Surg Oncol Date: 2009-03-31 Impact factor: 5.344

Review 6. Triple-negative breast cancer: role of specific chemotherapy agents.

Authors: Steven J Isakoff
Journal: Cancer J Date: 2010 Jan-Feb Impact factor: 3.360

7. Triple negative breast carcinoma is a prognostic factor in Taiwanese women.

Authors: Che Lin; Su-Yu Chien; Li-Sheng Chen; Shou-Jen Kuo; Tsai-Wang Chang; Dar-Ren Chen
Journal: BMC Cancer Date: 2009-06-18 Impact factor: 4.430

8. Continued Exploration of Bevacizumab in Breast Cancer.

Authors: Rita S Mehta; Min-Ying Su
Journal: Ann Surg Oncol Date: 2010-02 Impact factor: 5.344

9. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.

Authors: Jason A Zell; Walter Y Tsang; Thomas H Taylor; Rita S Mehta; Hoda Anton-Culver
Journal: Breast Cancer Res Date: 2009-02-19 Impact factor: 6.466

10. Evaluation of a Keratin 1 Targeting Peptide-Doxorubicin Conjugate in a Mouse Model of Triple-Negative Breast Cancer.

Authors: Azam Saghaeidehkordi; Shiuan Chen; Sun Yang; Kamaljit Kaur
Journal: Pharmaceutics Date: 2021-05-05 Impact factor: 6.525